Therese Hennig, MPAS, PA-C, advanced practice leader for the division of Hematologic Malignancies and Cellular Therapy, has been named director of Oncology Advanced Practice for Duke Cancer Institute.
"In her new role, Therese will provide oversight and direction for establishing and maintaining a system for standards for oncology advanced practice including quality, education, practice, professional development, and clinical operations," said Kim Slusser, MSN, RN, CHPN, NEA-BC, assistant VP, DUHS/Chief Oncology Nursing Services, Duke Cancer Institute. "She will collaborate with health system, PDC, DCI, department, and division leadership to ensure safe and high quality care models across the continuum of care for oncology."
Hennig has been recognized for her clinical expertise and leadership and has been instrumental in the design of provider practice models within the division—optimizing physician and APP practice to increase access, quality and patient care delivery.
Hennig is a graduate of the Duke University Physician Assistant Program and received her Masters in Physician Assistant Studies from the University of Nebraska, DLP. She is an active member of the American Academy of Physician Assistants and Advanced Practitioner Society of Hematology and Oncology, lectures on principles of stem cell transplantations at the Duke University Physician Assistant Program, and has published and presented on multiple topics in cellular therapy.
Hennig's new role is effective June 1.